![]()
![]()
在高影响力期刊发表论文,从来不是“把实验做完、文章写好”这么简单。从医学写作的逻辑、数据如何被编辑快速理解,到稿件是否真正匹配期刊定位、以及作者如何与编辑有效沟通,每一个环节都会直接影响论文的最终去向。
3月27日下午,Wiley携手西子乳腺癌论坛,邀请9本国际肿瘤学期刊的主编与资深编辑亲临现场,从编辑视角出发,系统解析高影响力论文如何“写对、投对”,帮助研究者少走弯路,把研究成果送到真正合适的期刊。
到场期刊包括:
跨学科旗舰期刊Advanced Science(IF 14.3)
探索生物医学与前沿技术交叉的Interdisciplinary Medicine(IF 13.6)
从细胞生物学到临床医学、强调转化价值的MedComm(IF 10.7)
聚焦癌症分子机制与转化诊疗的MedComm – Oncology(IF 2.2)
覆盖临床研究、癌症生物学与预防的Cancer Medicine(IF 3.1)
深耕肿瘤精准医学与个体化治疗的Precision Medical Sciences(IF 0.6)
涵盖癌症全链条、鼓励数据驱动型研究的Cancer Reports(IF 1.9)
广覆盖临床护理、公共卫生与流行病学的Health Science Reports(IF 2.1)
从研究到政策、关注全球公共卫生挑战的Public Health Challenges(ESCI收录)
无论你的研究处于哪个阶段,都可以在这里找到对应期刊的编辑,面对面沟通交流。
同样值得期待的是,Wiley’s Advanced Portfolio全新旗舰肿瘤学期刊Advanced Oncology将在现场举行国内首场创刊仪式,欢迎关注和参与!
活动亮点:
编辑面对面答疑:从医学科学传播、稿件结构设计、数据可视化,到如何与编辑高效沟通,编辑们将分享一线经验与实用建议
Advanced Oncology国内首次亮相:线上线下参与创刊仪式,聆听主编解读新刊,全面了解 Wiley 肿瘤学新旗舰。
多刊联合征稿:9 本期刊联合开放征稿,提交摘要即可 一稿多投,并获得与编辑直接沟通的机会。
时间:2026年3月27日(周五)13:40 -17:30
地点:杭州洲际酒店上海厅,线上同步直播
报名方式:扫描下方二维码即可免费报名,获取开播提醒,并订阅直播回放。
活动日程:
![]()
Wiley乳腺癌 · 精选文章合集:
为助力乳腺癌研究成果的传播,我们从本次参与活动的9本期刊中,精心挑选出了多篇乳腺癌相关研究文章——覆盖基础机制、转化策略,临床预后与疾病负担等多个方面。扫描下方二维码即可阅读全文:
Advanced Science
Pan-Cancer Single-Cell and Spatial-Resolved Profiling Reveals the Immunosuppressive Role of APOE+ Macrophages in Immune Checkpoint Inhibitor Therapy
作者:Chuan Liu, Jindong Xie, Bo Lin, Weihong Tian, Yifan Wu, Shan Xin, Libing Hong, Xin Li, Lulu Liu, Yuzhi Jin, Hailin Tang, Xinpei Deng, Yutian Zou, Shaoquan Zheng, Weijia Fang, Jinlin Cheng, Xiaomeng Dai, Xuanwen Bao, Peng Zhao
Advanced NanoBiomed Research
Mannose-modified Cationic Liposome-based mRNA Therapeutics for Improved Triple-negative Breast Cancer Immunotherapy
作者:Kexin Deng, Juping Sun, Junyu Liu, Yuqi Zhang, Wanwan Liu, Xiaobin Li, Han Wu, Juan Li, Jisong Zhang, Chanyuan Jin, Can Yang Zhang
Cancer Medicine
Breast Cancer Brain Metastasis: Current Evidence and Future Directions
作者:Hongna Sun, Junnan Xu, Shuang Dai, Yiwen Ma, Tao Sun
Cancer Reports
Global Burden of Female Breast Cancer and Its Association with Socioeconomic Development Status, 1990–2044
作者:Jingya Zhang, Yongbo Lu, Ning Zhang, Zeru Yu, Haorao Li, Rongxin He, Ying Mao, Bin Zhu
Health Science Reports
Risk Factors for Self-reported High Symptom Cluster Burdens in Patients with Breast Cancer Undergoing Chemotherapy in China
作者:Qingmei Huang, Xuqian Zong, Changrong Yuan, Meimei Shang, Rong Yan, Yeping Zheng, Meie Niu, Yang Yang, Fulei Wu
Interdisciplinary Medicine
TROP2-guided Aggregation-induced Emission-luminogen Nanoparticles Overcome Sacituzumab Govitecan Resistance via Mitochondrial Oxidative Stress and Immunogenic Cell Death in Triple-negative Breast Cancer
作者:Nisha Wu, Shujuan Ma, Xiaohong Liu, Min Zhao, Na Sun, Rui Wang, Shanlin Huang, Minghao Sun, Ying Liu, Jun Jiang, Mengyuan Wang, Yi Zhang, Ying Gong, Xiaowei Qi
MedComm - Oncology
Breast Cancer Brain Metastasis: Bridging Biological Mechanisms to Therapeutic Innovations
作者:Jing Feng, Yuwei Tao, Fengkai Li, Suling Liu
Precision Medical Sciences
Nomogram for Predicting Early Shoulder Joint Dysfunction after Breast Cancer Surgery
作者:Jing Yu, Fang Cheng, Miao Ye, Jing Hang, Yu-Qing Fang, Qing Hu, Qing-Yue Hu
Public Health Challenges
Disease Burden, Risk Factors, and Temporal Trends in Breast Cancer in Low- and Middle-Income Countries: A Global Study
作者:Mingjun Gao, Sofia Laila Wik, QinYao Yu, FanYu Xue, Sze Chai Chan, Shui Hang Chow, Yusuff Adebayo Adebisi, Claire Chenwen Zhong, Don Eliseo Lucero-Prisno III, Martin CS Wong, Junjie Huang, Global Health Focus Epidemiology Group (GHFEG)
上下滑动查看文章
联合征稿同步开启:
本次Wiley 与西子乳腺癌会议开展联合征稿。扫码提交摘要,一次投递即可覆盖 9 本期刊。编辑团队将根据您预留的联系方式,提供个性化反馈与投稿建议。也欢迎您现场与编辑直接交流,获取更具针对性的指导。
关于Advanced Oncology:
![]()
Advanced Oncology是一本聚焦肿瘤学全领域的开放获取期刊——从基础癌症生物学到转化医学,再到临床实践,均属于其发表范畴。我们致力于发表突破性癌症研究,探索未知领域,推动科学发现向临床价值转化,为全球癌症研究者和肿瘤学家搭建知识共享平台。Advanced Oncology现已正式开放投稿,欢迎赐稿!
期刊主页:https://advanced.onlinelibrary.wiley.com/journal/25128647
投稿链接:https://submission.wiley.com/journal/ADON
特别声明:以上内容(如有图片或视频亦包括在内)为自媒体平台“网易号”用户上传并发布,本平台仅提供信息存储服务。
Notice: The content above (including the pictures and videos if any) is uploaded and posted by a user of NetEase Hao, which is a social media platform and only provides information storage services.